Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Appili Therapeutics Inc. (APLIF) had Weighted-Average Shares Outstanding (Diluted) of 121.27M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$-0.01M |
|
$0.19M |
|
-- |
|
$-0.01M |
|
$1.75M |
|
$-1.76M |
|
$1.97M |
|
$0.21M |
|
$0.21M |
|
$0.21M |
|
$0.21M |
|
$0.19M |
|
$0.21M |
|
$-1.76M |
|
$-1.76M |
|
121.27M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
121.27M |
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$2.17M |
|
$0.01M |
|
$0.01M |
|
$2.18M |
|
$11.28M |
|
$0.53M |
|
$0.53M |
|
$11.81M |
|
$-9.63M |
|
$-9.63M |
|
$-9.63M |
|
121.27M |
|
| Cash Flow Statement Financials | |
$0.62M |
|
$-0.00M |
|
$0.14M |
|
$0.07M |
|
$0.88M |
|
$0.81M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.19 |
|
-- |
|
-- |
|
-0.06 |
|
-0.92 |
|
100.00% |
|
20353.67% |
|
20353.67% |
|
-- |
|
-2442.24% |
|
-2213.06% |
|
$0.62M |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
-- |
|
-0.01 |
|
-0.01M |
|
-2.13% |
|
-2.13% |
|
9.43% |
|
-2.26% |
|
$-0.08 |
|
$0.01 |
|
$0.01 |
|